231 related articles for article (PubMed ID: 34675921)
1. Short Chain Fatty Acids Prevent Glyoxylate-Induced Calcium Oxalate Stones by GPR43-Dependent Immunomodulatory Mechanism.
Jin X; Jian Z; Chen X; Ma Y; Ma H; Liu Y; Gong L; Xiang L; Zhu S; Shu X; Qi S; Li H; Wang K
Front Immunol; 2021; 12():729382. PubMed ID: 34675921
[TBL] [Abstract][Full Text] [Related]
2. Short-Chain Fatty Acids Reduced Renal Calcium Oxalate Stones by Regulating the Expression of Intestinal Oxalate Transporter SLC26A6.
Liu Y; Jin X; Ma Y; Jian Z; Wei Z; Xiang L; Sun Q; Qi S; Wang K; Li H
mSystems; 2021 Dec; 6(6):e0104521. PubMed ID: 34783577
[TBL] [Abstract][Full Text] [Related]
3. The relationship between gut microbiota and short chain fatty acids in the renal calcium oxalate stones disease.
Liu Y; Jin X; Hong HG; Xiang L; Jiang Q; Ma Y; Chen Z; Cheng L; Jian Z; Wei Z; Ai J; Qi S; Sun Q; Li H; Li Y; Wang K
FASEB J; 2020 Aug; 34(8):11200-11214. PubMed ID: 32645241
[TBL] [Abstract][Full Text] [Related]
4. Sirtuin 3 suppresses the formation of renal calcium oxalate crystals through promoting M2 polarization of macrophages.
Xi J; Chen Y; Jing J; Zhang Y; Liang C; Hao Z; Zhang L
J Cell Physiol; 2019 Jul; 234(7):11463-11473. PubMed ID: 30588609
[TBL] [Abstract][Full Text] [Related]
5. Loss of the androgen receptor suppresses intrarenal calcium oxalate crystals deposition via altering macrophage recruitment/M2 polarization with change of the miR-185-5p/CSF-1 signals.
Zhu W; Zhao Z; Chou F; Zuo L; Liu T; Yeh S; Bushinsky D; Zeng G; Chang C
Cell Death Dis; 2019 Mar; 10(4):275. PubMed ID: 30894518
[TBL] [Abstract][Full Text] [Related]
6. Macrophage Function in Calcium Oxalate Kidney Stone Formation: A Systematic Review of Literature.
Taguchi K; Okada A; Unno R; Hamamoto S; Yasui T
Front Immunol; 2021; 12():673690. PubMed ID: 34108970
[TBL] [Abstract][Full Text] [Related]
7. CCR2 antagonist attenuates calcium oxalate-induced kidney oxidative stress and inflammation by regulating macrophage activation.
Wang X; Xie L; Liu C
Exp Anim; 2024 May; 73(2):211-222. PubMed ID: 38199255
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for stone disease.
Dominguez-Gutierrez PR; Kwenda EP; Khan SR; Canales BK
Curr Opin Urol; 2020 Mar; 30(2):183-189. PubMed ID: 31913203
[TBL] [Abstract][Full Text] [Related]
9. Calcium Oxalate Differentiates Human Monocytes Into Inflammatory M1 Macrophages.
Dominguez-Gutierrez PR; Kusmartsev S; Canales BK; Khan SR
Front Immunol; 2018; 9():1863. PubMed ID: 30186283
[TBL] [Abstract][Full Text] [Related]
10. The Protective Roles of Estrogen Receptor
Zhu W; Zhao Z; Chou FJ; Zuo L; Liu T; Bushinsky D; Chang C; Zeng G; Yeh S
Oxid Med Cell Longev; 2019; 2019():5305014. PubMed ID: 31178964
[TBL] [Abstract][Full Text] [Related]
11. STAT6 promoting oxalate crystal deposition-induced renal fibrosis by mediating macrophage-to-myofibroblast transition via inhibiting fatty acid oxidation.
Yuan T; Xia Y; Pan S; Li B; Ye Z; Yan X; Hu W; Li L; Song B; Yu W; Li H; Rao T; Lin F; Zhou X; Cheng F
Inflamm Res; 2023 Dec; 72(12):2111-2126. PubMed ID: 37924395
[TBL] [Abstract][Full Text] [Related]
12. Identification of Resolvin D1 and Protectin D1 as Potential Therapeutic Agents for Treating Kidney Stones.
Wang B; Wei J; Huangfu Q; Gao F; Qin L; Zhong J; Wen J; Ye Z; Yang X; Liu H
Oxid Med Cell Longev; 2022; 2022():4345037. PubMed ID: 35251472
[TBL] [Abstract][Full Text] [Related]
13. Sirt1 inhibits kidney stones formation by attenuating calcium oxalate-induced cell injury.
Ye QL; Wang DM; Wang X; Zhang ZQ; Tian QX; Feng SY; Zhang ZH; Yu DX; Ding DM; Xie DD
Chem Biol Interact; 2021 Sep; 347():109605. PubMed ID: 34333021
[TBL] [Abstract][Full Text] [Related]
14. Vinegar reduced renal calcium oxalate stones by regulating acetate metabolism in gut microbiota and crystal adhesion in rats.
Liu Y; Jin X; Ma Y; Sun Q; Li H; Wang K
Int Urol Nephrol; 2022 Oct; 54(10):2485-2495. PubMed ID: 35852714
[TBL] [Abstract][Full Text] [Related]
15. Klotho inhibits the formation of calcium oxalate stones by regulating the Keap1-Nrf2-ARE signaling pathway.
Ahmatjan B; Ruotian L; Rahman A; Bin M; Heng D; Yi H; Tao C; le G; Mahmut M
Int Urol Nephrol; 2023 Feb; 55(2):263-276. PubMed ID: 36336747
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of AT1R/IP3/IP3R-mediated Ca
Hong SY; Yang YY; Wang SG; Qin BL
Chem Biol Interact; 2023 Sep; 382():110636. PubMed ID: 37454925
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyproline stimulates inflammation and reprograms macrophage signaling in a rat kidney stone model.
Kumar P; Yang Z; Lever JM; Chávez MD; Fatima H; Crossman DK; Maynard CL; George JF; Mitchell T
Biochim Biophys Acta Mol Basis Dis; 2022 Sep; 1868(9):166442. PubMed ID: 35562038
[TBL] [Abstract][Full Text] [Related]
18. Discovering inhibitor molecules for pathological crystallization of CaOx kidney stones from natural extracts of medical herbs.
Li S; Macaringue EGJ; Zhou D; Shi P; Tang W; Gong J
J Ethnopharmacol; 2022 Feb; 284():114733. PubMed ID: 34644589
[TBL] [Abstract][Full Text] [Related]
19. Renal macrophage migration and crystal phagocytosis via inflammatory-related gene expression during kidney stone formation and elimination in mice: Detection by association analysis of stone-related gene expression and microstructural observation.
Okada A; Yasui T; Fujii Y; Niimi K; Hamamoto S; Hirose M; Kojima Y; Itoh Y; Tozawa K; Hayashi Y; Kohri K
J Bone Miner Res; 2010 Dec; 25(12):2701-11. PubMed ID: 20577968
[TBL] [Abstract][Full Text] [Related]
20. Kidney injury in response to crystallization of calcium oxalate leads to rearrangement of the intrarenal T cell receptor delta immune repertoire.
Zhu C; Liang Q; Liu Y; Kong D; Zhang J; Wang H; Wang K; Guo Z
J Transl Med; 2019 Aug; 17(1):278. PubMed ID: 31438987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
